Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taisei Mushiroda

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
Journal of Human Genetics|June 26, 2013
Special Section on Pharmacogenomics: recent advances and future directionsTaisei Mushiroda, Kathleen M Giacomini, Michiaki Kubo
Drug Metabolism and Pharmacokinetics|November 2, 2011
Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transportersKazuma Kiyotani, Taisei Mushiroda, Yusuke Nakamura, et al.
Journal of Human Genetics|May 10, 2013
Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studiesKazuma Kiyotani, Taisei Mushiroda, Hitoshi Zembutsu, et al.
The Australian and New Zealand Journal of Psychiatry|January 24, 2020
Human leukocyte antigen DRB1*04:05 and clozapine-induced agranulocytosis/granulocytopeniaTakeo Saito, Masashi Ikeda, Taisei Mushiroda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomicsSiew-Kee Low, Atsushi Takahashi, Taisei Mushiroda, et al.
Frontiers in Pharmacology|September 9, 2020
Editorial: Big Data, Pharmacogenomics and Real-World Research in PharmacologyJames Cheng-Chung Wei, Wei-Chiao Chang, Taisei Mushiroda
BMC Genetics|June 15, 2016
ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese populationKoya Fukunaga, Hiroshi Nakagawa, Toshihisa Ishikawa, et al.
Epilepsy Research|March 19, 2021
Characteristics of adverse drug reactions associated with antiepileptics at a tertiary children's hospital in Japan: A retrospective observational cohort studyKeiko Hikino, Yuichi Abe, Kazumi Sakashita, et al.
European Journal of Clinical Pharmacology|September 9, 2011
CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected ZimbabweansMilimo Maimbo, Kazuma Kiyotani, Taisei Mushiroda, et al.
JMIR Research Protocols|September 21, 2019
The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-AnalysisKeiko Hikino, Shinobu Kobayashi, Erika Ota, et al.
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
Journal of Human Genetics|June 26, 2013
Special Section on Pharmacogenomics: recent advances and future directionsTaisei Mushiroda, Kathleen M Giacomini, Michiaki Kubo
Drug Metabolism and Pharmacokinetics|November 2, 2011
Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transportersKazuma Kiyotani, Taisei Mushiroda, Yusuke Nakamura, et al.
Journal of Human Genetics|May 10, 2013
Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studiesKazuma Kiyotani, Taisei Mushiroda, Hitoshi Zembutsu, et al.
The Australian and New Zealand Journal of Psychiatry|January 24, 2020
Human leukocyte antigen DRB1*04:05 and clozapine-induced agranulocytosis/granulocytopeniaTakeo Saito, Masashi Ikeda, Taisei Mushiroda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2014
Genome-wide association study: a useful tool to identify common genetic variants associated with drug toxicity and efficacy in cancer pharmacogenomicsSiew-Kee Low, Atsushi Takahashi, Taisei Mushiroda, et al.
Frontiers in Pharmacology|September 9, 2020
Editorial: Big Data, Pharmacogenomics and Real-World Research in PharmacologyJames Cheng-Chung Wei, Wei-Chiao Chang, Taisei Mushiroda
BMC Genetics|June 15, 2016
ABCB1 polymorphism is associated with atorvastatin-induced liver injury in Japanese populationKoya Fukunaga, Hiroshi Nakagawa, Toshihisa Ishikawa, et al.
Epilepsy Research|March 19, 2021
Characteristics of adverse drug reactions associated with antiepileptics at a tertiary children's hospital in Japan: A retrospective observational cohort studyKeiko Hikino, Yuichi Abe, Kazumi Sakashita, et al.
European Journal of Clinical Pharmacology|September 9, 2011
CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected ZimbabweansMilimo Maimbo, Kazuma Kiyotani, Taisei Mushiroda, et al.
JMIR Research Protocols|September 21, 2019
The Influence of Beta-2 Adrenergic Receptor Gene Polymorphisms on Albuterol Therapy for Patients With Asthma: Protocol for a Systematic Review and Meta-AnalysisKeiko Hikino, Shinobu Kobayashi, Erika Ota, et al.
Pageof 17